CTX
Filed: April 16, 2018
Research and development services in the field of pharmaceuticals for the treatment of attention deficit/hyperactivity disorder…
Owned by: Cingulate Therapeutics LLC
Serial Number: 87878032
CINGULATE THERAPEUTICS
Filed: April 16, 2018
Research and development services in the field of pharmaceuticals for the treatment of attention deficit/hyperactivity disorder…
Owned by: Cingulate Therapeutics LLC
Serial Number: 87878039
CINGULATE THERAPEUTICS
Filed: April 16, 2018
Research and development services in the field of pharmaceuticals for the treatment of attention deficit/hyperactivity disorder…
Owned by: Cingulate Therapeutics LLC
Serial Number: 87878041
CINGULATE
Filed: July 15, 2019
Pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD)
Owned by: Cingulate Therapeutics LLC
Serial Number: 88514366
MASTERY
Filed: January 30, 2020
conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention deficit hyperactivity…
Owned by: Cingulate Therapeutics LLC
Serial Number: 88778608
ACCOMPLISH
Filed: January 30, 2020
conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention deficit hyperactivity…
Owned by: Cingulate Therapeutics LLC
Serial Number: 88778614
ENFOQUS
Filed: February 3, 2020
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owned by: Cingulate Therapeutics LLC
Serial Number: 88783012
ENFOQIS
Filed: February 3, 2020
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owned by: Cingulate Therapeutics LLC
Serial Number: 88783014
TYMPREZI
Filed: February 3, 2020
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owned by: Cingulate Therapeutics LLC
Serial Number: 88783017
TAYLERZA
Filed: February 3, 2020
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owned by: Cingulate Therapeutics LLC
Serial Number: 88783020
IVOQUS
Filed: February 3, 2020
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owned by: Cingulate Therapeutics LLC
Serial Number: 88783023
TRODESCA
Filed: February 3, 2020
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owned by: Cingulate Therapeutics LLC
Serial Number: 88783030
ACCOMPLISH
Filed: July 27, 2023
conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention deficit hyperactivity…
Owned by: Cingulate Therapeutics LLC
Serial Number: 98104260
ENFOQUS
Filed: February 22, 2024
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owned by: Cingulate Therapeutics LLC
Serial Number: 98416390
ENFOQIS
Filed: February 22, 2024
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owned by: Cingulate Therapeutics LLC
Serial Number: 98416392
